Fenzian is still at the research and development stage. The commercial development of the business depends on the scientific and clinical trial data which is only now emerging at an accelerating rate.
Whilst Fenzian has already proved to be a safe and effective treatment, clinical trial evidence is necessary to warrant the investment in widespread commercial availability. Fenzian is at the forefront of (even the pioneer!) the rapidly emerging interest in electroceutical treatments. To have an unsullied record of 14 years and over 900,000 treatments with no adverse reports confirms the value of this safe, non-invasive and effective treatment.